RecruitingNot ApplicableNCT07676305

6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics

Impact of 6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics in Adults withT2D


Sponsor

University of British Columbia

Enrollment

20 participants

Start Date

Feb 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.


Eligibility

Min Age: 19 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Exercise for people with type 2 diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise

In both groups participants will complete treadmill walking on 3 days per week for 6 weeks. During the first week participants will walk continuously for 21 minutes during each training session which will be increased to 32 minutes per training session for weeks 2-6. In both groups the treadmill speed and grade will be set to elicit 40-50% heart rate reserve. In the BFR group the cuffs will be inflated based on each participants individualized limb occlusion pressure (LOP). The cuffs will remain inflated for the entire session but will deflate for 1 min every 10 min based on safety recommendations. The percentage of LOP will progressively increase over the course of the intervention. Weeks 1 and 2 will be completed at 60% LOP, after which pressure will increase by 5% each subsequent week, corresponding to 65%, 70%, 75%, and 80% LOP during weeks 3, 4, 5, and 6, respectively.


Locations(1)

University of British Columbia Okanagan

Kelowna, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07676305


Related Trials